Enzymatic activities of Candida tropicalis isolated from hospitalized patients

Medical Mycology

Volumn 48, Issue 1, 2010, Pages 207-210

  Galan Ladero M A ^a   Blanco, M T ^a   Sacristan B ^a   Fernandez Calderon M C ^a   Perez Giraldo C ^a   Gomez Garcia A C ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Aspartyl proteinases; Candida tropicalis; Esterases; Hemolysins; Phospholipases

Indexed keywords

ASPARTIC PROTEINASE; ESTERASE; HYDROLASE; PHOSPHOLIPASE; VIRULENCE FACTOR; ENZYME; ESTER; FUNGAL PROTEIN; PHOSPHOLIPID; PROTEIN;

ARTICLE; CANDIDA ALBICANS; CANDIDA TROPICALIS; CONTROLLED STUDY; ENZYME ACTIVITY; FUNGUS ISOLATION; HOSPITAL PATIENT; HUMAN; NONHUMAN; STRAIN DIFFERENCE; CANDIDIASIS; ENZYMOLOGY; HEMOLYSIS; HOSPITALIZATION; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY;

CANDIDA; CANDIDA ALBICANS; CANDIDA TROPICALIS;

CANDIDA TROPICALIS; CANDIDIASIS; ENZYMES; ESTERS; FUNGAL PROTEINS; HEMOLYSIS; HOSPITALIZATION; HUMANS; PHOSPHOLIPIDS; PROTEINS; VIRULENCE FACTORS;

EID: 74949105177     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780902801242     Document Type: Article

References (23)

1. Peman J, Canton E, Gobernado M. Spanish ECMM Working Group on Candidaemia. Epidemiology and antifungal susceptibility of Candida species isolated from blood: Results of a 2-year multicentre study in Spain. Eur J Clin Microbiol Infect Dis 2006; 24: 23-30.
2. Cheng MF, Yu KW, Tang RB, et al. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999. Diagn Microbiol Infect Dis 2004; 48: 33-37.
3. De Bernardis F, Sullivan PA, Cassone A. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med Mycol. 2001; 39: 303-313.
4. Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses. 2005; 48: 365-377.
5. Gokce G, Cerikcioglu N, Yagci A. Acid proteinase, phospholipase, and biofi lm production of Candida species isolated from blood cultures. Mycopathologia 2007; 164: 265-269.
6. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7-14.
7. Luo G, Samaranayake LP, Yau JYY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 2001; 39: 2971-2974.
8. Blanco MT, Hurtado C, Perez-Giraldo C, et al. Effect of ritonavir and saquinavir on Candida albicans growth rate and in vitro activity of aspartyl proteinases. Med Mycol 2003; 41: 167-170.
9. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122-143.
10. Kumar CP, Menon T, Sundararajan T, et al. Esterase activity of Candida species isolated from immunocompromised hosts. Rev Iberoam Micol 2006; 23: 101-103.
11. Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microbiol 2000; 38: 4626-4628.
12. Koga-Ito CY, Lyon JP, Vidotto V, De Resende MA. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia 2006; 161: 219-223.
13. Williamson MI, Samaranayake LP, MacFarlane TW. Phospholipase activity as a criterion for biotyping Candida albicans. J Med Vet Mycol 1986; 24: 415-417.
14. Tsang C, Chu FC, Leung WK, et al. Phospholipase, proteinase and haemolytic activities of Candida albicans isolated from oral cavities of patients with type 2 diabetes mellitus. J Med Microbiol 2007; 56: 1393-1398.
15. Asencio MA, Garduno E, Perez-Giraldo C, et al. Exposure to therapeutic concentrations of ritonavir, but not saquinavir, reduces secreted aspartyl proteinase of Candida parapsilosis. Chemotherapy 2005; 51: 252-255.
16. Fotedar R, Al-Hedaithy SS. Comparison of phospholipase and proteinase activity in Candida albicans and Candida dubliniensis. Mycoses 2005; 48: 62-67.
17. Kantarcioglu AS, Yucel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 2002; 45: 160-165.
18. Yamamoto T, Nohara K, Uchida K, Yamaguchi H. Purifi cation and characterization of secretory proteinase of Candida albicans. Microbiol Immunol 1992; 36: 637-641.
19. Tamura NK, Negri MF, Bonassoli LA, Svidzinsk TI. Virulence factors for Candida spp recovered from intravascular catheters and hospital workers hands. Rev Soc Bras Med Trop 2007; 40: 91-93.
20. Birinci A, Cihan CC, Bilgin K, Acuner C, Durupinar B. Phospholipase activity of Candida species isolated from different clinical samples. Mikrobiyol Bul 2005; 39: 205-209.
21. Samaranayake YH, Dassanayake RS, Jayatilake JA, et al. Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection. J Med Microbiol 2005; 54: 583-593.
22. Aktas E, Yigit N, Ayyildiz A. Esterase activity in various Candida species. J Int Med Res 2002; 30: 322-324.
23. Yucesoy M, Marol S. Determination of esterase activity of Candida varieties. Mikrobiyol Bul 2003; 37: 59-63.